DGX 주요 통계
고가
233.21
개시가
228.00
거래량
1.54M
저가
223.42
전일 종가
227.90
거래대금
353.86M
52주 최고가
237.78
상대 거래량
1.414
변동폭 (%)
4.30%
52주 최저가
165.78
회전율
1.39%
시가총액
25.14B
PER (TTM)
24.17
PER (연간)
25.689
PBR
3.35
PSR
2.18
주당순이익(EPS)
9.427
배당금(TTM)
3.737
배당수익률
1.44%
발행주식수
110.69M
통화 단위
USD
DGX 가격 수익률
7 일
30 일
90 일
180 일
연초 이후
1 년
DGX 자금 흐름 분포
DGX 일일 공매도 거래량
DGX 공매도 잔고 내역
DGX 주식 스냅샷
As of 2026-07-26, the Quest Diagnostics Incorporated (DGX) stock price today is 227.86. Based on this price, the company has a market capitalization of $25.14B, with a P/E ratio of 24.17.
On 2026-07-26, DGX traded between 223.42 and 233.21. Today’s stock price is 1.99% above the daily low and 2.29% below the daily high, placing DGX 중간 부근에 its most recent trading range.
Trading volume currently stands at 1.54M, compared with an average daily volume of 1.09M. This suggests that trading activity is 평소 수준을 웃도는 than usual.
Over the past year, Quest Diagnostics Incorporated shares have traded between 165.78 and 237.78. At today’s price, DGX is 37.45% above its 52-week low and 4.17% below its 52-week high.
DGX 관련 뉴스
소개 DGX
회사 이름
Quest Diagnostics Incorporated
섹터
Health Services
산업
Services to the Health Industry
거래소
NYSE
직원 수
57,000
랏 크기
100
공식 웹사이트
통화 단위
USD
Quest Diagnostics is a leading independent provider of diagnostic testing, information, and services in the US. The company generates over 97% of its revenue through clinical testing, anatomic pathology, esoteric testing, and substance abuse testing with specimens collected at its national network of roughly 2,400 patient service centers, as well as multiple doctors offices and hospitals. The firm also runs a much smaller diagnostic solutions segment that provides clinical trials testing, risk-assessment services, and information technology solutions.
Related Stocks
